- Register a BioLINCC Account, enabling you to request resources
- View the NHLBI Biorepository video: NHLBI Biospecimen and Data Repository Program: Advancing Medical Research
- Learn about the results of the first 6 years of BioLINCC
Search for Study Datasets and/or Biospecimens
Featured News - 9 Items
Biospecimens from the Clarification of Optimal Anticoagulation Through Genetics (COAG) study are now available for request.
A new study, Cure Sickle Cell Hematopoietic Stem Cell Collection (CureSC-SCD), has been posted to BioLINCC. Specimens from this study are available for requests.
Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) study are now available for request.
This funding opportunity is to support meritorious exploratory research relevant to the NHLBI mission using the biospecimen collections that are stored in the NHLBI Biorepository and that are available through BioLINCC. The first application due date is June 21, 2022.
For more information on RFA-HL-23-018 please visit: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-018.html
A new study, Dietary Intervention Study in Children Follow-Up Study (DISC06), has been posted to BioLINCC. Data and specimens from this study are available for requests.
Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET) study are now available for request.
Biospecimens from 8 AsthmaNet studies are now available for request.
This includes the AsthmaNet Proof of Concept Study of Alendronate for Asthma (ALFA), AsthmaNet Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children (APRIL) and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children (OCELOT), AsthmaNet Best African American Response to Asthma Drugs (BARD), AsthmaNet Individualized Therapy For Asthma in Toddlers (INFANT) and Acetaminophen Versus Ibuprofen in Children With Asthma (AVICA), AsthmaNet Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment, AsthmaNet Steroids in Eosinophil Negative Asthma (SIENA), AsthmaNet Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS), and AsthmaNet Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA) studies.
Funding Opportunity: PAR-23-036 Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses using existing human datasets in areas relevant to the National Heart, Lung, Blood Diseases and Sleep Disorders Institute (NHLBI) scientific mission. The FOA aims to stimulate the use of existing human datasets to investigate novel scientific ideas, and/or generate new models, systems, tools, or technologies that have the potential for significant impact on biomedical or biobehavioral research. Generation of new primary data is not allowed.
For more information on PAR-23-036 please visit:
Biospecimens from the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network – Biology and Longitudinal Epidemiology of PETAL COVID-19 Observational Study (BLUE CORAL) study are now available for request.
Data have been updated for the Dietary Intervention Study in Children (DISC). This update includes the addition of metabolomics and hormone data.
A new study, Heart Failure Network (HFN) - EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE), has been posted to BioLINCC. Data from this study are available for requests.
Data have been updated for the Framingham Heart Study (FHS) Third Generation (Gen III), OMNI 2, and New Offspring (NOS) Cohorts. This update includes the addition of Brain MRI data.